Search PubMed⌕ Search

Biomedical subjects

D Tranter

Publications and source records attributed to D Tranter.

10 recordsLinked to original sources
PubMed2001

Monitor: molecules and profiles.

Monitor provides an insight into the latest developments in drug discovery through brief synopses of recent presentations and publications together with expert commentaries on the latest technologies. There are two sections: Molecules summarizes the chemistry and the pharmacological significance and biological relevance of new molecules reported in the literature and on the conference scene; Profiles offers commentary on promising lines of research, emerging molecular targets, novel technology, advances in synthetic and separation techniques and legislative issues.

Journal Article↗
PubMed2000

Goodbye.

Explore the source record for details and available documents.

Journal Article↗
PubMed1999

Preparing for the new millennium.

Since being introduced to the field of drug discovery at Zeneca Pharmaceuticals in 1991, it has become apparent to me that a blizzard of revolutionary novel approaches has swept through the pharmaceutical industry. Now, the discovery process has become completely transformed and the race to develop commercially successful drugs is now taking place in a very different realm. Rapid advances in automation, combinatorial chemistry, high-throughput screening (HTS), genomics, proteomics and bioinformatics appear to be principally responsible for driving such a rapidly evolving discovery process. In these exciting times for pharmaceutical R&D, it is a delight for me to take over the Editor's reins of Drug Discovery Today.

Journal Article↗
PubMed1999

Preparing for change.

'The pharmaceutical industry is seemingly poised on a precipice of intense pressures and challenges'

Journal Article↗